/>i- On May 28, 2025, the U.S. Food and Drug Administration (FDA) issued a “no questions” letter to Wildtype, Inc. in response to the California-based company’s pre-market evaluation filings for their cultured salmon cell material.
- FDA’s letter marks the first instance FDA has issued a “no questions” letter for cultured salmon material, indicating the agency has no further questions regarding the product’s safety under its intended conditions of use. Wildtype’s cultured salmon joins cultured chicken cell material from GOOD Meat Inc. and Upside Foods and cultured pork fat cells from Mission Barns as one of four cell-cultured products to receive a “no questions” letter from FDA.
- Although Wildtype’s salmon is already being sold at a restaurant in Portland, Oregon (see here), Wildtype may face challenges bringing their products to other markets. As we have previously reported, many states have imposed cultivated product bans.
- Keller and Heckman will continue to monitor developments involving cell cultivated food products.
Cultured Salmon Company Receives “No Questions” Letter From FDA
Saturday, July 19, 2025
Current Public Notices
Published: 18 July, 2025
Published: 10 July, 2025
Published: 7 July, 2025
Published: 7 July, 2025
Published: 1 July, 2025
Published: 26 June, 2025
Published: 24 June, 2025
Published: 24 June, 2025
Published: 24 June, 2025
Published: 23 June, 2025
